GetTopicDetailResponse(id=20031044e4ee, topicName=達洛魯胺, introduction=達洛魯胺, content=達洛魯胺，在國內(nèi)更多稱為達羅他胺, image=null, comments=1, allHits=1098, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=10, adminEncryptionId=7a3710, adminName=醫(yī)者仁者, createdBy=7a3710, createdName=醫(yī)者仁者, createdAvatar=, createdTime=Thu Mar 10 15:30:08 CST 2022, time=2022-03-10, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=124167, tagList=[TagDto(tagId=124167, tagName=達洛魯胺)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=1201407, encodeId=cff0120140e08, content=<a href='/topic/show?id=20031044e4ee' target=_blank style='color:#2F92EE;'>#達洛魯胺#</a>，在國內(nèi)更多稱為<a href='/topic/show?id=a45b1044e3f1' target=_blank style='color:#2F92EE;'>#達羅他胺#</a>, objectTitle=ASCO GU 2021: 達洛魯胺治療非轉(zhuǎn)移性去勢抵抗性前列腺癌療效分析, objectType=article, longId=207265, objectId=388d20e265f5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021218/1613630009250_2299762.jpg, objectUrl=/article/show_article.do?id=388d20e265f5, replyNumber=0, likeNumber=115, createdTime=2022-03-10, rootId=0, userName=醫(yī)者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=388d20e265f5, moduleTitle=ASCO GU 2021: 達洛魯胺治療非轉(zhuǎn)移性去勢抵抗性前列腺癌療效分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=388d20e265f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
醫(yī)者仁者
2022-03-10
